Former light heavyweight boxing king Sergey Kovalev, who will return from the ring after more than a year, tested positive for synthetic testosterone, according to lead boxing writer Dan Rafael.

Oracular reporter Rafael brought the news to 236,000 on Twitter Thursday afternoon – exactly two weeks before Kovalev was due to face Uzbek-born Bektemir Melikuziev in Moscow’s Luzhniki Stadium.

Should Rafael’s report prove true, it is almost certain that this fight will not go on, and at 37, Kovalev’s career could even be in doubt.

“Sergey Kovalev tested positive for synthetic testosterone,” said Rafael.

BREAKING: Sergey Kovalev tested positive for synthetic testosterone. I received the VADA letter detailing the positive test. Means that his DAZN headliner on January 30th with Bektemir “Bek Bully” Melikuziev will probably be canceled. #Boxing

– Dan Rafael (@ DanRafael1) January 14, 2021

“I received it [anti-doping agency] VADA letter with the details of the positive test. Means his January 30th DAZN headliner with [Melikuziev] will likely be canceled. “

Fans reacted in frustration at the prospect of Kovalev’s return for the first time since his knockout loss to Canelo Alvarez.

The Russian had to face Sullivan Barrera in April before this fight was canceled because of the Covid-19 pandemic.

Also on
Russian boxing superstar Sergey Kovalev escapes the offense but deserves three years probation for alleged bloody assault on a woman

Kovalev had suffered just three losses in his impressive 38-fight career before facing Canelo, two of which were against revered former master Andre Ward.

“Krusher” hit the headlines in October when he pleaded guilty shortly before the start of a criminal trial against a woman whose nose was broken in California.

He was sentenced to three years probation and had to take an anger management course and pay legal fees.

Also on
Coronavirus KO: Russia’s Kovalev shares protective suit training video days after Barrera fight was canceled (VIDEO)


Please enter your comment!
Please enter your name here